Cargando…
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors
BACKGROUND: List prices of tumor necrosis factor (TNF) inhibitors drastically increased during the last decade, but previous research has shown that half of these increases were offset by rising manufacturer discounts. It remains unclear to what extent manufacturers’ discounts have offset increases...
Autores principales: | San-Juan-Rodriguez, Alvaro, Piro, Vincent M, Good, Chester B, Gellad, Walid F, Hernandez, Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788267/ https://www.ncbi.nlm.nih.gov/pubmed/33377437 http://dx.doi.org/10.18553/jmcp.2021.27.1.112 |
Ejemplares similares
-
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2019) -
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019
por: Dickson, Sean, et al.
Publicado: (2023) -
Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015) -
Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016) -
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019
por: Dickson, Sean R., et al.
Publicado: (2023)